UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Bukwang to change clinical design for Covid-19 drug candidate
by Kim Chan-hyuk
2020-06-30 13:18
Samsung Bioepis’ drug to join bevacizumab biosimilar competition in Europe
by Kim Chan hyuk
2020-06-29 16:08
Vivozon to start P3b trial of nonnarcotic analgesics in US
by Lee Han-soo
2020-06-26 17:13
Helixmith pushes ahead with P3-2 trial for neuropathic pain treatment
by Lee Han-soo
2020-06-26 16:38
Celltrion tops pharmaceutical brand reputation in June
by Park Gi-taek
2020-06-26 15:23
라인
10 more Korean drugmakers nestle in Boston to enter US market
by Kim chan-hyuk
2020-06-26 14:12
Alteogen signs $3.8-billion tech transfer deal with a global pharma
by Shim Hyun-tai
2020-06-25 16:19
‘Use NEWS score system to detect high-risk Covid-19 patients early’
by Song Soo-youn
2020-06-25 15:07
Hanmi, Novartis in patent dispute over diabetes drug
by Kim Yun-mi
2020-06-25 13:59
Hanmi Science Presents 6 Great Visions for Post COVID-19
by Lee Han-soo
2020-06-24 18:02
라인
GSK sure about Dovato’s changing HIV treatment paradigm
by Lee Han-soo
2020-06-24 12:11
Hanmi to sell prostatism drug in Japan
by Shim Hyun-tai
2020-06-23 18:17
[News Focus] Pfizer Korea's restructuring enters into last-minute tug-of-war with union
by Lee Han-soo
2020-06-23 16:51
Labor-management dispute runs deep at MSD Korea
by Kim Yun-mi
2020-06-23 12:06
‘Pfizer’s Vyndaqel, Vyndamax do not deserve rare disease pricing’
by Kim Yun-mi
2020-06-22 17:19
라인
New diabetes drug Steglatro fails to prove cardiovascular benefit
by Kim Yun-mi
2020-06-19 14:55
Yuyu to export SD Biosensor's Covid-19 test kit
by Lee Han-soo
2020-06-19 14:48
HK inno.N nabs FDA nod for trial of gastric acid blocker
by Lee Han-soo
2020-06-18 17:39
AZ’s Imfinzi wins extra indication for small-cell lung cancer
by Kim Yun-mi
2020-06-18 15:55
5 key factors in successful secondary packaging and device assembly strategy
by Lee Han-soo
2020-06-18 15:52
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top